AGP Picks
View all

East Timor Technology Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on East Timor Technology Press.

Press releases published on September 24, 2026

MediciNova Announces Completion of Last Patient, Last Visit in the Double-Blind Portion of the Phase 2b/3 COMBAT-ALS Trial of MN-166 (Ibudilast)
Disbo Launches Outsourced Check Disbursement for Personal Injury Law Firm Trust Accounts
Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring
aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis
From NVIDIA to MEXC: Autheo Expands the Markets Behind Its Internet Operating System
Kasvu Therapeutics Raises €30 Million Series A Financing Round led by Hadean Ventures to Advance its Novel TrkB Potentiator into Clinical Development Targeting Neuropsychiatric Disorders
BOOST Pharma Selected to Showcase Phase III Ready Lead Program BT-101 at the 2026 Cell & Gene Meeting on the Mesa
Ona Therapeutics advances as a clinical-stage company and appoints Aleix Prat, MD, PhD, as Chief Medical Officer
Airia and Nephos Technologies announce strategic partnership to close gap between AI platform control and data governance
Flen Health Chooses AGC Biologics to Manufacture Recombinant Enzymes for Next-Generation Wound Treatment
フレン・ヘルス、次世代の創傷治療用組換え酵素の製造に、AGCバイオロジクスを選定
Flen Health, 차세대 상처 치료제용 재조합 효소 생산 위해 AGC Biologics 선정
Flen Health Memilih AGC Biologics untuk Mengeluarkan Enzim Rekombinan bagi Rawatan Luka Generasi Baharu
Flen Health 选择 AGC Biologics 生产新一代伤口治疗用重组酶
Flen Health 選擇 AGC Biologics 生產用於新一代傷口治療的重組酶
 Final Phase 2a data reinforce the profile of BIOX-101, selected for a late-breaking oral presentation at the World Stroke Congress
Liveteq LLC Introduces Songer AI Music Generator for Text-to-Song Creation
Rhino Investments Group Acquires Dual Grocery-Anchored Power Center in Mount Prospect, Illinois
Addex Therapeutics to Report 2026 Half-Year Financial Results and Host Conference Call on September 28, 2026
Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

East Timor Technology Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.